Treatment group | # homes completing study | Days post-Treatment1 | |||||||
---|---|---|---|---|---|---|---|---|---|
Day 0 | Day 7 | Day 14 | Day 21 | Days 28–30 | Days 40–45 | Days 54–60 | |||
Afoxolaner1 | 23 | Geomean2 | 18.19 | 1.69 | 0.72 | 1.09 | 0.43 | 0.09 | 0.00 |
(Std dev) | (18.01) | (6.26) | (4.65) | (8.87) | (0.89) | (1.28) | (0.00) | ||
(Range) | (5–86) | (0–26) | (0–17) | (0–43) | (0–3) | (0–6) | (0–0) | ||
% control3 | 90.73 | 96.04 | 93.99 | 97.66 | 99.49 | 100.00 |